Beta
242989

Potential COX2 mediated Therapeutic effect of Ciprofloxacin

Article

Last updated: 28 Dec 2024

Subjects

-

Tags

Healthcare research

Abstract

Fluoroquinolones (FQs) are broad-spectrum, synthetic antibiotics that inhibit bacterial DNA synthesis. 
FQs directly block DNA synthesis in the bacterial cell via inhibition the activity of two tetrameric, ATPdependent, homologous type II topoisomerase enzymes: topoisomerase II-called DNA gyrase and 
topoisomerase IV. FQs are also active against eukaryotic topoisomerase II. This property results in 
inhibition of this enzyme and pro apoptotic effects on mammalian tumor cell lines, including human 
cells, and creates the possibility of using FQs as potential anticancer drugs. In one study, it was found 
that ciprofloxacin induced the production of prostaglandin E2 in monocytes in a concentrationdependent manner.
________________

DOI

10.21608/mjmr.2021.242989

Authors

First Name

Marwa

Last Name

Eisa

MiddleName

A.

Affiliation

Department of Biochemistry, Faculty of Pharmacy, Minia University, Minia, Egypt.

Email

-

City

-

Orcid

-

First Name

Moustafa

Last Name

Fathy

MiddleName

-

Affiliation

Department of Biochemistry, Faculty of Pharmacy, Minia University, Minia, Egypt.

Email

-

City

-

Orcid

-

First Name

Maiiada

Last Name

Nazmy

MiddleName

H.

Affiliation

Department of Biochemistry, Faculty of Pharmacy, Minia University, Minia, Egypt.

Email

-

City

-

Orcid

-

Volume

32

Article Issue

3

Related Issue

34262

Issue Date

2021-07-01

Receive Date

2022-06-09

Publish Date

2021-07-01

Page Start

47

Page End

57

Online ISSN

2682-4558

Link

https://mjmr.journals.ekb.eg/article_242989.html

Detail API

https://mjmr.journals.ekb.eg/service?article_code=242989

Order

242,989

Type

Review Article

Type Code

2,215

Publication Type

Journal

Publication Title

Minia Journal of Medical Research

Publication Link

https://mjmr.journals.ekb.eg/

MainTitle

Potential COX2 mediated Therapeutic effect of Ciprofloxacin

Details

Type

Article

Created At

23 Jan 2023